Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma

Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation

(2011) Ruey-Hwang Chou et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching

(2011) Anna M Werling et al.   HISTOPATHOLOGY

Overexpression of aldo-keto reductase 1C2 is associated with disease progression in patients with prostatic cancer

(2010) Kuo-Hsuan Huang et al.   HISTOPATHOLOGY

ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion

(2010) Sofia Papanikolaou et al.   HISTOPATHOLOGY

Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

(2009) A. Perotti et al.   ANNALS OF ONCOLOGY

Epstein-Barr Virus Latent Membrane Protein-1 Effects on Junctional Plakoglobin and Induction of a Cadherin Switch

(2009) K. H.Y Shair et al.   CANCER RESEARCH

Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival

(2008) J. Li et al.   CLINICAL CANCER RESEARCH

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China

(2008) Weiyi Fang et al.   Journal of Translational Medicine